Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

BACKGROUND: The World Health Organization (WHO) recommends that the cost effectiveness of introducing human papillomavirus (HPV) vaccination is considered before such a strategy is implemented. However, developing countries often lack the technical capacity to perform and interpret results of econom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jit, Mark, Demarteau, Nadia, Elbasha, Elamin, Ginsberg, Gary, Kim, Jane, Praditsitthikorn, Naiyana, Sinanovic, Edina, Hutubessy, Raymond
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123559/
https://ncbi.nlm.nih.gov/pubmed/21569406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-9-54
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados